A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

NCT04352595 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Hemay808

Sponsor

Tianjin Hemay Pharmaceutical Co., Ltd